Drug Database
FA

Factor VIII (ReFacto AF / Xyntha)

✓ Approved

Sobi · F8 · 重组蛋白

什么是 Factor VIII?

Factor VIII 是一种重组蛋白,由Sobi研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)。

药物档案

商品名ReFacto AF, Xyntha
公司Sobi
药物类别重组蛋白, 细胞治疗
分子靶点F8
给药途径Injectable (Others), Intravenous (IV)
状态Approved

作用机制

分子靶点

Factor VIII 作用于 1 个分子靶点:

F8coagulation factor VIII (AHF, FVIII)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

Factor VIII 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Congenital, familial and genetic disordersFactor VIII deficiency✓ Approved

相关研究文献

PubMedBMC psychiatry2026-11-19

Revision of the Hypomania Checklist-32 with a sample of Chinese psychiatric inpatients.

Li Wei W, Chen Lu L, Zhong Jie J

This study aimed to complete the revision of the Hypomania Checklist-32 (HCL-32) and systematically validate its psychometric properties in a sample of mainland Chinese psychiatric inpatients. A total of 519 consecutively recruited psychiatric inpatients were enrolled and completed the Chinese version of the HCL-32, the Generalized Anxiety Disorder-7 scale (GAD-7), the Patient Health Questionnaire-9 (PHQ-9), and the Symptom Checklist-90 (SCL-90). After quality control, 462 patients with complete and valid assessment data were included in the final statistical analysis. (1) The revised Chinese HCL-32 scale (HCL-32-R) comprised 25 items and yielded a stable three-factor structure, namely active/elevated, irritable/distractible, and impulsive/stimulating. Both exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) validated the robustness of this three-factor model. (2) All items demonstrated satisfactory factor loadings and aligned well with their corresponding factor dimensions. The Cronbach's α coefficient for the full HCL-32-R scale was 0.828, with coefficients of 0.944 for Factor 1, 0.742 for Factor 2, and 0.775 for Factor 3. The scale also exhibited favorable convergent validity, discriminant validity, and known-group discriminative capacity. (3) The total score of HCL-32-R, as well as the scores of Factor 2 and Factor 3, showed significant positive correlations with the total scores of the PHQ-9, GAD-7, and SCL-90 scales. (4) Statistically highly significant differences in HCL-32-R total scores were observed across distinct psychiatric diagnostic categories. The majority of psychometric indicators for the revised HCL-32-R meet acceptable psychometric standards. The scale demonstrates preliminary application potential for the assessment of hypomanic symptoms in Chinese psychiatric inpatient populations. However, due to the lack of validated optimal cut-off values, sensitivity and specificity data, and test-retest reliability evidence, HCL-32-R cannot be recommended for routine clinical screening use at this stage, and is only suitable for research-based symptom assessment pending further large-sample validation. Not applicable.

PMID 43052857
阅读全文 →
PubMedJournal of experimental & clinical cancer research : CR2026-11-19

Mapping the NFYA 3'UTR landscape identifies alternative polyadenylation as a targetable vulnerability in prostate cancer.

Pagani Giulia G, Casirati Chiara C, Pandini Cecilia C, Fornezza Stefania S et al.

Alternative polyadenylation (APA) is increasingly recognized as a pervasive oncogenic mechanism that reshapes post-transcriptional gene regulation and promotes tumor aggressiveness. Whether APA contributes to the dysregulation of NFYA-encoding the regulatory subunit of the oncogenic transcription factor NF-Y-in prostate cancer (PCa) remains largely uncharacterized. We interrogated bulk, single cell and 3'-end RNA-sequencing data from PCa cell lines and patient samples to re-annotate and quantify the usage of NFYA 3'UTRs. The functional consequences of APA were assessed using reporter assays. NFYA APA was experimentally reprogrammed using CRISPR/Cas9-mediated deletion and antisense oligonucleotide (ASO)-based masking of polyadenylation signals, followed by in vitro and in vivo phenotypic analyses. Four functional NFYA 3'UTR isoforms were identified, with one predominantly used across cell lines and tissues. PCa displayed pervasive NFYA 3'UTR shortening, which correlated with tumor grade and metastatic disease, increased NF-YA protein abundance, and enhanced proliferation. 3'UTR lengthening was instead observed upon induction of cellular quiescence or after Enzalutamide treatment. Mechanistically, 3'UTR lengthening reduced NF-YA protein expression through decreased mRNA stability, impaired translation, and enhanced nuclear retention, rather than increased miRNA-mediated repression. Enforced NFYA 3'UTR lengthening in PCa cells via CRISPR/Cas9 or ASOs diminished NF-YA protein levels and suppressed aggressive tumor traits both in vitro and in vivo. These findings establish NFYA APA as a critical determinant of NF-YA oncogenic output and downstream tumor-promoting programs, and as a previously unrecognized driver of PCa progression. Importantly, they provide proof-of-concept for gene-specific, APA-directed therapeutic strategies. ASO-mediated modulation of polyadenylation indeed emerges as a clinically translatable approach to fine-tune oncogene expression, thus opening new avenues for RNA-based precision interventions in aggressive PCa.

PMID 43053175
阅读全文 →
PubMedMagnetic resonance in medicine2026-11-19

Fast Voxelwise SNR Estimation for Iterative MRI Reconstructions.

Dalmaz Onat O, Abraham Daniel D, Toews Alexander R AR, Chaudhari Akshay S AS et al.

To develop a fast, general-purpose framework for voxelwise noise characterization in iterative MRI reconstructions, recovering the image-domain noise variance, the primary quantity from which SNR, g -factor, and related image-quality metrics are derived. The framework addresses both the intractability of closed-form formulas beyond Cartesian sampling and the long runtime of pseudo multiple replica (PMR). A stochastic noise estimator is proposed that operates in the image domain by Probing the Image-space noise COvariance matrix (PICO) with random probe images. Complex random-phase probes attain minimum kurtosis and reduce estimator variance in the tested reconstruction. PICO was validated against analytical benchmarks and PMR references using Cartesian knee data ( R = 2 ), physical brain phantom data ( R = 2 , 3 , 4 ), in vivo non-Cartesian brain data ( R = 2 ), and compressed-sensing knee reconstructions ( R = 2 ). In Cartesian reconstructions, PICO accurately reproduced analytical SENSE g -factor maps. In non-Cartesian reconstructions, it achieved 1 % g -factor NRMSE ≈ 11 . 9 × faster than PMR in a phantom and ≈ 2 . 81 × faster in vivo, with the efficiency advantage persisting at higher acceleration. For compressed sensing, the Jacobian-based estimator produced noise maps consistent with PMR and computed them 1 . 84 × faster at equal sample counts. Agreement worsened at large added-noise amplitudes and moderate TV strengths. PICO targets the exact covariance of fixed linear reconstructions and a first-order covariance for nonlinear reconstructions, providing a computationally efficient alternative to PMR. By reusing existing reconstruction primitives, it could help incorporate voxelwise noise maps into reconstruction workflows.

PMID 43053180
阅读全文 →
PubMedBMC gastroenterology2026-11-19

Predictive factors and long-term outcomes of anastomotic leakage closure in Crohn's disease: a retrospective cohort study.

Liu Wei W, Qi Weilin W, Ge Xiaolong X, Wei Ziyao Z et al.

The management of anastomotic leakage (AL) in Crohn's disease (CD) lacks standardized protocols. Identifying predictors of successful AL closure is crucial for surgeons to select the optimal treatment strategy. This study aimed to identify the predictive factors for AL closure in patients with CD and assess long-term outcomes. CD patients with AL between January 2012 and December 2022 were included in this study. Logistic regression models were used to identify the predictors of AL closure. Kaplan-Meier analysis and Cox regression models were used to evaluate long-term outcomes and risk factors for surgical recurrence. Sixty-two patients with AL from 1068 CD patients who underwent bowel surgery were included in the study, of whom 40 (64.5%) achieved AL closure through conservative treatment. Leakage from enteroenteric anastomosis was associated with significantly greater odds of AL closure (odds ratio [OR] = 5.07, p = 0.04), while preoperative use of anti-tumor necrosis factor (anti-TNF) was a risk factor (OR = 0.19, p = 0.03). Patients with AL closed had surgical recurrence rates of 2.5%, 8.3%, 14.7%, and 24.1% at 1, 2, 3, and 5 years, respectively. Maintenance anti-TNF therapy was the only factor associated with a reduced risk of surgical recurrence (hazard ratio [HR] = 0.06, p = 0.009). Conservative treatment was a viable option for AL management in CD patients. Patients with leakage from enteroenteric anastomosis and those naïve to anti-TNF therapy had higher AL closure rates. Maintenance anti-TNF therapy was associated with a lower risk of surgical recurrence.

PMID 43052741
阅读全文 →
PubMedNaunyn-Schmiedeberg's archives of pharmacology2026-11-19

Targeting neuroinflammation in diabetic peripheral neuropathy: Mechanistic perspectives, phytochemical pharmacology, and translational challenges.

Narapusetty Naidu N, Marabathuni V Jhansipriya VJ

Diabetic peripheral neuropathy (DPN) is a debilitating neurodegenerative complication of diabetes mellitus characterized by the convergence of metabolic dysregulation, microvascular ischemia, and chronic low-grade neuroinflammation. While intensive glycemic control and cardiometabolic risk-factor modification slow neuropathy progression-most notably in type 1 diabetes mellitus (T1DM)-approved central analgesic pharmacotherapies primarily manage nociceptive symptoms without directly reversing established structural axonal loss. Preclinical studies indicate that endoneurial inflammation mediated via Toll-like receptor 4 (TLR4), nuclear factor-kappa B (NF-κB), and the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome contributes to microvascular dysfunction and Schwann cell dedifferentiation. Investigational phytochemicals, including curcumin, resveratrol, berberine, and quercetin, modulate these inflammatory and oxidative nodes in experimental rodent models. However, clinical translation remains constrained by poor aqueous solubility, extensive phase II enterocytic and hepatic conjugation, active efflux, and restricted transport across the diseased blood-nerve barrier (BNB). Using a structured narrative synthesis and a three-tier evidence hierarchy, this Brief Report distinguishes established human pathogenic and clinical trial evidence from preclinical mechanistic findings, critically evaluates clinical trial limitations (sample size, duration, and subjective endpoints), and defines rigorous pharmacokinetic and pharmacodynamic criteria required to validate nanocarrier-mediated endoneurial target engagement.

PMID 43052394
阅读全文 →
PubMedLuminescence : the journal of biological and chemical luminescence2026-11-19

Enhanced Power Conversion Efficiency in Lead-Free CH3NH3SnI3-Based Perovskite Solar Cell Using SCAPS Simulation.

Srivastava Vaibhava V

Perovskite-based solar cells (PSCs) have emerged as the fastest-growing photovoltaic technology in recent years. While lead (Pb)-based PSCs currently deliver the highest efficiencies, their inherent toxicity poses significant environmental and health concerns. To address this, Pb-free perovskite materials have been explored. This study focuses on a Pb-free PSC architecture consisting of FTO/GO/CH3NH3SnI3/CZTS/C. In this design, fluorine-doped tin oxide (FTO) serves as transparent conductive window layer, graphene oxide (GO) functions as electron transport layer (ETL), copper zinc tin sulfide (CZTS) acts as hole transport layer (HTL), and carbon is employed as the back contact. The device is modelled using Solar Cell Capacitance Simulator (SCAPS-1D), with variations applied to the thicknesses, defect density, bandgap of absorber (CH3NH3SnI3) layer, work function of back contact and series & shunt resistance, as well as to operating temperature range (300K-480K). Optimal performance is obtained with an absorber acceptor density of 1015 cm-3, HTL acceptor density of 1018 cm-3, and ETL donor density of 1019 cm-3. Increasing defect density (Nt) is found to degrade device efficiency. The maximum power conversion efficiency (PCE) of 31.27% with an open-circuit voltage (Voc) of 1.0741 V, short-circuit current density (Jsc) of 35.28 mA/cm2, and a fill factor (FF) of 82.51%.

PMID 43053263
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多Factor VIII